Close
Steven Herrine, MD

Education

B.A.
Oberlin College, Oberlin, OH

M.D., Jefferson Medical College, Philadelphia, PA

Internship and Residency in Internal Medicine
Hospital of the University of Pennsylvania, Philadelphia, PA

Fellowship in Gastroenterology and Hepatology
Thomas Jefferson University Hospital, Philadelphia, PA

Clinical Interests
Viral Hepatitis
Transplant Hepatology
Chronic Liver Disease

Research Interests
Hepatitis C
Fulminant hepatic failure and intracranial hypertension
Chronic liver disease
Medical education

Papers

Armenti VT, Herrine SK, Radomski JS, Moritz MJ. Pregnancy after liver transplantation. Liver Transplantation. 2000;6:671-685.

Baig N, Herrine SK, Rubin R. Liver Disease in Diabetes Mellitus. Clinics of Laboratory Medicine. 2001;21:1, 193-207.

Herrine, SK. The epidemiology of hepatitis C virus in the United States. Infections in Medicine, 1999;16:111-117.

Nazarian LN, Feld RI, Herrine SK, Webner D, Lev-Toaff AS, Johnson PT, Storey LA, Needleman L. Safety and efficacy of sonographically guided random core biopsy for diffuse liver disease. J Ultrasound Med. 2000;19:537-541.

Herrine SK. Approach to the Patient with Chronic Hepatitis C. Ann Intern Med 2002;136:747-57

Zhang X-M, Mitchell DG, Shi H, Holland GA, Parker L, Herrine SK, Pasqualin D, Rubin R. Chronic hepatitis C activity: correlation with lymphadenopathy on MR imaging. American Journal of Radiology(AJR). 2002;179:1-6

Book Chapters

Herrine SK, Muñoz SJ. Lebertransplantation - Indikationen, Vorbereitung und Langzeitbetreuung [Liver Transplantation: indications, preparations and long term management]. In Hahn EG, Riemann JF, editors. Klinische Gasroenterologie. Stuttgart: Georg Thieme Verlag, 1996.

Herrine SK, Zern, MA. Alpha-1-Antitrypsin Deficiency. In Wu GY and Israel J., eds. Diseases of the Liver and Bile Ducts. Totowa, NJ: Humana Press, 1998.

Herrine SK, Runyon, BA. Paracentesis. In Merli G, DiMarino AJ. eds. Clinics Atlas of Office Procedures. Philadelphia, PA: Saunders, 1999.

Herrine SK, Muñoz SJ. Lebertransplantation - Indikationen, Vorbereitung und Langzeitbetreuung [Liver Transplantation: indications, preparations and long term management]. In Hahn EG, Riemann JF, editors. Klinische Gastroenterologie: in 2 B”nden. Stuttgart: Georg Thieme Verlag, 2000

Zamani S, Herrine SK. Viral Hepatitis. In Edmundowicz SA, ed. 20 Common Problems in Gastroenterology. New York, McGraw-Hill, 2002

Abstracts

Herrine SK, Weinberg DS. Education intervention improves practitioners' knowledge of hepatitis C infection. Hepatology 1999;30:483A.

Chojnacki KA, Radomski JS, Rubin R, Moritz MJ, Armenti VT, Wilson GA, Conn MI, Herrine SK. Results of liver transplantation for nodular regenerative hyperplasia. Hepatology 1999;30:660A.

Sjogren MH, Wu G, Herrine SK., Raufman JP, Bacon BR, Epstein M, Medoff J, Chen S, Waters B, Krawitt E, Sjogren RW, Herrera J. Efficacy of Interferon Alfacon-1 in non-responders and relapsers to interferon and ribavirin. Gastoenterology. 2000;1188:6738A..

Michael B, Dunn SR, Ma W, Herrine SK. Analysis of liver function in hemodialysis patients with anti-HCV antibody. Journal of the American Society of Nephrology 2000;11:288A.

Herrine SK, Weinberg DS, Greenfield SM, Shaw EW. Interferon alpha-2b/ribavirin in both high and standard dose induces sustained response in previous interferon monotherapy non-responders. Hepatology 2000;32:352A.

Sjogren MH, Wu G, Herrine SK., Raufman JP, Bacon BR, Epstein M, Medoff J, Chen S, Waters B, Krawitt E, Sjogren RW, Herrera J. High-dose Interferon Alfacon-1 is a treatment option for non-responders and relapsers to combined therapy with interferon and ribavirin. Hepatology 2000;32:352A.

Herrine SK, Brown R; Esposito S; Lok A; Galati JS; Bernstein DE; Campagna J, Pappas SC. Pegylated (40 kda) interferon alfa-2a (Pegasys) in combination with ribavirin, mycophenolate mofetil, amantadine, or amantadine plus ribavirin in patients that relapsed on rebetron therapy: a preliminary report of a randomized, multicenter efficacy and safety study. Gastroenterology. 2001;120:384A.

Kolodziejski TR, Rubin R, Stefanosky E, Herrine SK. End-stage renal disease patients with chronic hepatitis C infection undergoing renal transplant evaluation have mild hepatic histology. Hepatology. 2001;34:568A

Ma W, Rossi S, Michael B, Dunn S, Hyslop T, Herrine SK. Development of a HCV risk stratification algorithm for patients of chronic hemodialysis. Hepatology. 2001;34:574A

Afdhal N, Flamm S, Imperial JC, Malet PF, Tong M, Herrine SK, Brown R, Espositio S, Bernstein DE, Campagna JL. Analyses of 40kDa peginterferon alfa-2a (Pegasys) in combination with ribavirin, mycophenolate mofetil, amantadine, or amantadine plus ribavirinin patients that relapsed or did not respond to Rebetron therapy: a report of two randomized, multicenter, efficacy and safety studies. Hepatology. 2001;34:243A

Sapienza MS, Herrine SK, Porayko, MP, Rubin R, DiMarino, AJ, Weinberg DS. A pilot study to assess the effect of targeted COX-2 inhibition on liver histology in patients infected with hepatitis C virus. Gastroenterology. 2002;122:P-21